1. Introduction {#sec1-nutrients-09-00474}
===============

Fatty acids, and especially the omega-3 long-chain polyunsaturated fatty acids (*n*-3 LCPUFA), are being researched extensively for a wide array of health outcomes varying from, but not exclusive to, cardiovascular diseases, depression and cognition \[[@B1-nutrients-09-00474],[@B2-nutrients-09-00474],[@B3-nutrients-09-00474]\]. As in every health related field, randomized controlled supplementation trials are the gold standard to demonstrate efficacy of *n*-3 LCPUFA \[[@B4-nutrients-09-00474]\]. For these trials, voluntary participants are needed, however recruitment of participants can be challenging, especially when it involves research in children and adolescents (\<18 years) \[[@B5-nutrients-09-00474]\]. It has been reported that less than 31% of British studies funded by two funding bodies between 1994 and 2002 achieved their original recruitment target number \[[@B6-nutrients-09-00474]\]. Similarly, others have reported that up to 60% of the randomized controlled trials (RCT) fail to meet their participant target or need an extension \[[@B7-nutrients-09-00474]\] and this percentage might be even higher in paediatric and adolescent studies \[[@B8-nutrients-09-00474],[@B9-nutrients-09-00474]\]. However, even after the recruitment phase, difficulties with conducting research do not end, because drop-out and non-adherence are also common. Drop-out in RCT is normal and attrition rates can vary enormously from 0 up to 65% \[[@B10-nutrients-09-00474],[@B11-nutrients-09-00474],[@B12-nutrients-09-00474]\]. Compliance and adherence are often used interchangeably, but are not the exactly same. Compliance is the extent to which the behaviour of a person coincides with the advice given by a doctor or researcher. The term compliance has received criticism because of its paternalistic connotation \[[@B13-nutrients-09-00474]\] and because it implies patient passivity \[[@B14-nutrients-09-00474]\]. As a more neutral term, adherence has been suggested, which presumes that the person agrees with the advice given by a doctor or researcher \[[@B14-nutrients-09-00474]\]. We choose to use the term adherence in the current manuscript. Adherence issues, are common, with non-adherence ranging anywhere from 3.5 to 80% \[[@B15-nutrients-09-00474],[@B16-nutrients-09-00474]\]. One must also be aware that there is no one single definition of adherence. This means that somebody who is considered non-adherent in one study, might be considered adherent in another (e.g., one study defined a participant as non-adherent when the participant took less than 75% of the prescribed medicine or supplements, while another used a cut-off level of \<80%). As low recruitment rates, high drop-out and high non-adherence are common and have serious consequences \[[@B6-nutrients-09-00474],[@B17-nutrients-09-00474],[@B18-nutrients-09-00474]\], it is important to study factors which possibly affect recruitment, drop-out, and adherence rates.

In 2013, we started a one-year long double blind randomized *n*-3 LCPUFA supplementation trial in healthy Dutch adolescents called Food2Learn \[[@B19-nutrients-09-00474]\]. We experienced difficulties in the recruitment, drop-out and adherence of the study participants. Furthermore, many other n3- LCPUFA supplementation studies have had the same difficulties (personal communication). However, a review of recruitment, adherence and drop-out rates in nutrition interventions and in specific *n*-3 LCPUFA supplementation studies in children and adolescents does not, to our knowledge, exist. Therefore, the aim is to execute a thorough review to summarize *n*-3 LCPUFA supplementation studies in children (2--12 years) and adolescents (12--18 years) with regard to recruitment effort, drop-out and adherence rates.

2. Materials and Methods {#sec2-nutrients-09-00474}
========================

The Web of Science, PubMed and Ovid databases were searched up to 2 March 2017. We searched for human clinical trials including children aged between 2 and 18 years. We used the search terms: "Omega-3", "DHA", "EPA", "LCPUFA" and "PUFA" in combination with "RCT", "randomized controlled trial", "supplementation", "trial" or "fish oil" and "child\*)", "adolescent", "school", "preschool" or "toddler". Furthermore, a myriad of reviews were checked for additional studies \[[@B20-nutrients-09-00474],[@B21-nutrients-09-00474],[@B22-nutrients-09-00474],[@B23-nutrients-09-00474],[@B24-nutrients-09-00474],[@B25-nutrients-09-00474],[@B26-nutrients-09-00474],[@B27-nutrients-09-00474],[@B28-nutrients-09-00474],[@B29-nutrients-09-00474],[@B30-nutrients-09-00474],[@B31-nutrients-09-00474],[@B32-nutrients-09-00474],[@B33-nutrients-09-00474],[@B34-nutrients-09-00474],[@B35-nutrients-09-00474],[@B36-nutrients-09-00474],[@B37-nutrients-09-00474],[@B38-nutrients-09-00474],[@B39-nutrients-09-00474],[@B40-nutrients-09-00474]\] and reference lists of all articles were hand checked for additional references. Moreover, a search of the Cochrane library was also conducted to identify reviews regarding *n*-3 LCPUFA supplementation. The studies included in the Cochrane reviews were checked for inclusion in the current study \[[@B41-nutrients-09-00474],[@B42-nutrients-09-00474],[@B43-nutrients-09-00474],[@B44-nutrients-09-00474],[@B45-nutrients-09-00474],[@B46-nutrients-09-00474],[@B47-nutrients-09-00474],[@B48-nutrients-09-00474],[@B49-nutrients-09-00474],[@B50-nutrients-09-00474],[@B51-nutrients-09-00474],[@B52-nutrients-09-00474],[@B53-nutrients-09-00474],[@B54-nutrients-09-00474],[@B55-nutrients-09-00474],[@B56-nutrients-09-00474]\]. Lastly, for all included articles, the "cited by" option of Web of Science was checked (this option gives all articles that cite that specific article).

Studies were eligible for inclusion if they met the following criteria: (1) participants were aged between 2 and 18 years; (2) the study was a randomized placebo controlled *n*-3 LCPUFA supplementation trial; (3) the trial had at least 10 participants per treatment arm; (4) supplementation duration was at least 4 weeks; and (5) studies were published in English.

All papers were scanned by the first author, and the following information was extracted and entered in a database:

Participants' characteristics: Age range of participants, percentage of girls, healthy participants or those with a diagnosed disease, and country in which the study was executed;

Study characteristics: Number of participants, number of measurement moments (i.e., how often did participants have to come to the research facility/how often did they have to fill out questionnaires), number of measurements, treatment condition, placebo condition, form of supplementation, if capsules were used then how many, if supplementation was taken under supervision, if supplement was taken in multiple dosages or once a day, whether an incentive was provided, duration of the study, manner in which adherence was assessed, adherence rate, whether fatty acids were determined in blood, and percentage of people who quit the treatment (hereafter called drop-out); and

Recruitment characteristics: Invited/responded or screened, started, finished as well as method of recruitment, recruitment setting, and study period.

The recruitment characteristics were defined as follows: Invited: The total number of potential participants invited to participate;Responded: The total number of potential participants who responded to the invitation or the number of participants that were screened for participation in the study; andStarted: The number of participants who were assessed as eligible and began supplementation.

Furthermore, efficiency percentages were calculated, namely: started/invited (dividing the number of people who started by the number of people who were invited times 100), started/responded (dividing the number of people who started by the number of people who responded times 100) and started/finished (dividing the number of people who finished by the number of people who started times 100).

As a proxy for adherence to the CONSORT guidelines, we noted whether the article included a flow-chart and whether the article provided the dates defining the period of recruitment and follow-up.

Statistics
----------

All extracted data were entered in SPSS (IBM SPPS statistics for Windows, version 24, Armonk, NY, USA). SPSS was used to calculate averages and SDs for the participant' characteristics, study characteristics and recruitment characteristics. For comparison reasons outpatient clinics and hospitals were combined into one setting, which was named "hospital setting". Countries were furthermore grouped in regions for comparisons (Europe, USA/Canada, Asia, Middle East, Australia, Africa and South America). When a study mentioned multiple compliance rates, these were combined into one compliance rate for the whole study.

3. Results {#sec3-nutrients-09-00474}
==========

3.1. Study Characteristics {#sec3dot1-nutrients-09-00474}
--------------------------

The original search led to 2163 hits. Upon first screening, 1656 articles were excluded, additional screening of the whole articles led to a further exclusion of 173 articles. Additional checking of the reference lists of reviews, included articles and forward checking led to 15 more studies being included (see [Figure 1](#nutrients-09-00474-f001){ref-type="fig"}, adapted from \[[@B57-nutrients-09-00474]\]). Thus, in total, 90 papers, describing 75 studies, were included in this review. The characteristics of these studies can be found in [Table 1](#nutrients-09-00474-t001){ref-type="table"}. Fifteen studies focussed on healthy children. The other 60 studies focused on children with a disorder or disease, with attention deficit hyperactivity disorder (ADHD) being the most studied disorder (*n* = 21) (see [Table 1](#nutrients-09-00474-t001){ref-type="table"}). The majority of studies focussed on children (defined as aged between 2 and 12 years, *n* = 38) or both children and adolescents (*n* = 31). A minority of studies focussed only on adolescents (*n* = 6) (see [Table 1](#nutrients-09-00474-t001){ref-type="table"}). Duration of study varied from 4 to 52 weeks, with the majority of studies lasting 26 weeks or less (*n* = 59, 79%, see [Table 2](#nutrients-09-00474-t002){ref-type="table"}. Number of measurement moments (i.e., how often did participants have to come to the research facility/how often did they have to fill out questionnaires) varied from 2 to 16 with a mean of 3.7 (SD 2.7), the number of different measurements per moment varied from 1 to 19 with a mean of 4.9 (SD 3.7).

Two studies were published before the start of the CONSORT guidelines. Of the 73 studies that were published after the start of the CONSORT guidelines, 33 studies (45%) provided a flow diagram and 22 studies (30%) reported the dates defining the period of recruitment and follow-up.

3.2. Recruitment {#sec3dot2-nutrients-09-00474}
----------------

Most of the studies included in this review did not report the number of children or adolescents that were invited to participate in the study, as only 11 out of 75 studies mentioned the number of participants that were invited. The total number of people invited to participate varied from 46 to 3562 (Mean (M) = 804.5, SD = 1083.28). The percentage of invited participants that eventually started the study ranged from 2.4 to 87% (see [Table 3](#nutrients-09-00474-t003){ref-type="table"}).

Forty out of 75 studies mentioned the number of participants that responded to the invitation or were screened for the study and this varied from 30 to 1556, with 12 to 100% of these people actually starting the study.

Most studies did not specify the exact method(s) of recruitment, mostly just mentioning the recruitment setting. Most studies recruited their participants from a hospital or outpatient clinic setting (*n* = 33). Other settings from which participants were recruited were schools (*n* = 23) and the community (*n* = 15). Nine studies reported multiple settings for recruitment; one study recruited participants from a summer camp for children with ADHD and other disorders; one study recruited from an online registry; one study recruited participants from those who participated in earlier studies; and eight studies did not mention the recruitment setting.

Looking at the efficiency percentages for started/invited, started/responded or started/finished for studies including those with an illness (averages 43.5%, 63.5%, and 83.1%, respectively) and those without (averages 36.2%, 53.1%, and 84.2%, respectively), there was a clear difference for started/invited and started/responded but not for started/finished. A comparison for average rates between studies including only children (38.8%, 62.2%, and 85.4%, respectively), only adolescents (15.5%, 56.4%, and 87.8%, respectively) or both (53.4%, 52.7%, and 79.6%, respectively) showed notable differences. For different recruitment settings, there were mainly clear differences for started/invited. However, for all rates, the school setting had the highest average rate: hospital (17.7%, 56.8%, and 82.9%, respectively), community (29.9%, 57.1%, and 81.7%, respectively), and school (46.0%, 64.6%, and 86.8%, respectively). Lastly, when looking at these average efficiency percentages for the different continents, we also saw clear differences: Europe (35.3%, 64.3%, and 87.8%, respectively), North America (6.6%, 48%, and 77.7%, respectively), Asia (49.5%, 48.7%, and 92.6%, respectively), Africa (NA, 28%, and 91.1%, respectively), Middle East (33.2%, 64.6%, and 79%, respectively), Australia (72.9%, 69.5%, and 70.7%, respectively), and South America (54%, 93.2%, and 90.9%, respectively).

3.3. Supplementation {#sec3dot3-nutrients-09-00474}
--------------------

Most studies used capsules as the form of supplementation (*n* = 57), however there were also some other approaches (see [Table 2](#nutrients-09-00474-t002){ref-type="table"}). The number of capsules that participants were instructed to take also varied widely from 1 to 12 capsules a day, with some studies basing the dose per body weight of the participant (see [Table 2](#nutrients-09-00474-t002){ref-type="table"}). Moreover, a huge range of different placebos was used (see [Table 2](#nutrients-09-00474-t002){ref-type="table"}).

3.4. Adherence {#sec3dot4-nutrients-09-00474}
--------------

The included studies mentioned a wide variety of methods to measure adherence: capsule count (or product weighting) (*n* = 30), diaries or tick-off forms (*n* = 13), interviews face to face/via phone/ via e-mail (*n* = 11), taking the capsules under supervision (*n* = 8), and blood values (*n* = 5) (see [Table 4](#nutrients-09-00474-t004){ref-type="table"}). Thirteen studies used more than one method to assess adherence. Furthermore, 23 studies did not specify how or whether they assessed adherence. The way in which adherence was reported in the studies also varied greatly. Some studies mentioned percentages of capsules taken, the average number of capsules taken per day, blood values, or just mentioned that adherence was good or mentioned how many students were excluded due to non- adherence.

Twenty-five studies mentioned a specific percentage of adherence, which varied from 60 to 97%, mean 85% (SD 10.1). In addition, the levels of capsules that needed to be taken to be considered as being adherent differed per study, varying from 65 to 90%. Other studies defined adherence as the number of days of not taking capsules.

Looking at the adherence percentage between studies in healthy and diseased children, there seemed to be a slightly lower average adherence in diseased children (M = 83.7%, SD = 11.9), compared to healthy children (M = 87.6%, SD = 7.1). When we looked at the different age groups recruited, there seemed to be a lower average adherence in the child only group (M = 82.5%, SD = 9.5), compared to adolescents (M = 89.2%, SD = 1.1) or the combined group (M = 88.5%, SD = 11.2). The difference in average adherence in different recruitment settings was less clear; hospital (M = 86%, SD = 10.6), community (M = 89.5%, SD = 7.8), and school (M = 83.9%, SD = 11.6). The average adherence rate also differed between continents with a lower average rate in Australia and USA/Canada: Europe (M = 87.5%, SD = 9.3), USA/Canada (M = 78.7%, SD = 6.5), Asia (M = 92%, SD = 1.4), Africa (M = 95%, SD = 0.5), Australia (M = 79.7%, SD = 13.5), and South America (M = 94.5%, just one study). There seemed to be a tendency for higher average adherence when capsules were used (M = 88.2%, SD = 8.0) instead of food (M = 74.8%, SD = 14.3) or drinks (M = 81.5%, SD = 9.2), or other forms of supplementation (M = 80.3%, SD = 18.0). Some studies mentioned that participants took capsules under supervision, but they did not show a higher mean adherence (M = 82.8%, SD = 15.2) than those that did not have supervision of capsule intake (M = 86.2%, SD = 8.3). Seven studies, that reported adherence, reported that participants consumed capsules more than once a day while 12 studies, that reported adherence, mentioned that the capsules were only taken once a day. There was no difference in average adherence between those two methods of supplementation (M = 87.3%, SD = 9.4 vs. M = 87.6%, SD = 7.8). Fifteen studies, reporting adherence, mentioned talking to parents or participants either via telephone or face to face (or via e-mail) during the study about the supplementation to increase adherence \[[@B61-nutrients-09-00474],[@B67-nutrients-09-00474],[@B69-nutrients-09-00474],[@B70-nutrients-09-00474],[@B72-nutrients-09-00474],[@B90-nutrients-09-00474],[@B91-nutrients-09-00474],[@B107-nutrients-09-00474],[@B111-nutrients-09-00474],[@B113-nutrients-09-00474],[@B131-nutrients-09-00474],[@B134-nutrients-09-00474],[@B135-nutrients-09-00474],[@B136-nutrients-09-00474],[@B143-nutrients-09-00474]\]. The studies that included a phone call did not have a higher average adherence rate (M = 81.5%, SD = 9.5) than those that did not include a phone call (M = 86.2%, SD = 10.3). There were three studies that provided some form of incentive \[[@B98-nutrients-09-00474],[@B107-nutrients-09-00474],[@B146-nutrients-09-00474]\], however only one of these studies reported an adherence percentage. Forty-six studies mentioned that they took either blood or cheek samples, but only five studies mentioned that they used blood as an adherence measure \[[@B61-nutrients-09-00474],[@B85-nutrients-09-00474],[@B86-nutrients-09-00474],[@B117-nutrients-09-00474],[@B134-nutrients-09-00474]\].

3.5. Drop-Out {#sec3dot5-nutrients-09-00474}
-------------

Sixty-five of the 75 included studies mentioned a drop-out rate or included numbers which made it possible to calculate the drop-out rate. The average drop-out was 17% (SD 13%), but it varied between 0% and 58% (see [Table 4](#nutrients-09-00474-t004){ref-type="table"}). There was no clear difference in average drop-out rate between studies in healthy (mean = 16.5%, SD = 11.5) and diseased populations (M = 17.9%, SD = 13.7). There was a difference in average drop-out with regard to the recruited age group: children M = 15%, SD = 11.1), adolescents (M = 12.3%, SD = 7.3) or both (M = 21.5%, SD = 14.9); with a higher average drop-out rate in the combined age group.

There was also no clear difference in mean drop-out between recruitment setting: hospital (M = 15%, SD = 11.1), community (M = 18.2%, SD = 8.6) or school (M = 15.3%, SD = 13). Differences could be seen in the average drop-out according to the continent on which the study was executed: Europe (M = 13.3%, SD = 9.8), USA/Canada (M = 23.1%, SD = 11.6), Asia (M = 6.8%, SD = 7.4), Africa (M = 11.6%, SD = 3.9), Middle East (M = 20.1%, SD = 16.7), Australia (M = 34.9%, SD = 7.8), and South-America (M = 9.1%, just one study). When looking at different forms of supplementation, no clear differences in average drop-out rate could be seen: capsules (M = 17.5%, SD = 12.9), food (M = 14.1%, SD = 14.9), drinks (M = 19%, SD = 13.7), and others (M = 17.9%, SD = 8.4). Eight studies who reported drop-out rate mentioned that capsules were taken under supervision, this seemed to lead to somewhat lower average drop-out rate (M = 13%, SD = 15.6), compared to the 57 studies in which participants did not take the capsules under supervision (M = 17.9%, SD = 15.6). Sixteen studies that reported drop-out rate divided the capsules over multiple intake moments (M = 17.2%, SD = 9.3). This did not seem to increase or decrease the average drop-out rate if compared to those studies that specified one intake moment (M = 17.1%, SD = 13.6). Fourteen studies that noted drop-out rate reported that they contacted the participants during the study. Studies that did so seemed to have a slightly higher average drop-out rate (M = 20.4%, SD = 11.4) than studies that did not contact participants during the study (M = 16.5%, SD = 14.4). Of the studies that reported giving participants an incentive, two mentioned a drop-out rate, this was on average 15.3% (SD 20.4). Studies that did not state an incentive had an average drop-out rate of 17.4% (SD 12.7). Of the 65 studies that mentioned a drop-out rate, 50 specified a reason for drop-out (six did not have drop-out, and nine did not specify the drop-out). Fifty-two different reasons for drop-out were mentioned, with the most common reasons mentioned being lost to follow-up, poor or no compliance or inability to take supplement.

4. Discussion {#sec4-nutrients-09-00474}
=============

We conducted a thorough review to examine recruitment, adherence and drop-out rates in *n*-3 LCPUFA supplementation studies in children and adolescents, in order to identify strategies which can be implemented to improve those rates. Even though the CONSORT guidelines clearly state what data need to be included in the report of a RCT, the majority of the included studies did not provide a flow-chart (55% did not) or the dates defining the period of recruitment and follow-up (70% did not).

4.1. Recruitment {#sec4dot1-nutrients-09-00474}
----------------

The majority of studies provided minimal details about the recruitment process. The low number of studies that reported the number of participants that they invited and screened is, however, not uncommon in research studies as similar numbers were reported by Toerien et al. who studied 129 studies in six major journals \[[@B148-nutrients-09-00474]\]. The literature does give some suggestions for methods that could increase recruitment; for example, telephone calls to those who do not reply, an opt-out system (participants contact the researchers if they do not want to participate, please do note that this is not legal in all countries), including incentives, making trials open, and in person recruitment \[[@B149-nutrients-09-00474]\]. The use of clinical referral is also suggested to be related to higher recruitment rates, as most patients will have a trusting relationship with their doctor \[[@B150-nutrients-09-00474]\]. When we looked at the research setting (hospital, community, school), though, the mean started/invited rate and mean started/responded rate seemed to be slightly higher in the school setting. However, in the studies that looked at diseased populations, the average percentage efficiency of started/invited and started/responded was higher than studies looking at healthy populations (M = 43.5% vs. M = 36.2% and M = 63.5% vs. M = 53.1%, respectively).

It has been shown that in adolescents, giving monetary incentives does improve response rates and has a positive effect on their willingness to participate in studies \[[@B151-nutrients-09-00474]\]. However, the provision of monetary incentives might be considered unethical in children/adolescents \[[@B152-nutrients-09-00474],[@B153-nutrients-09-00474]\]. One might thus consider a form on non-monetary incentive, for example in Food2Learn participants received a cinema voucher \[[@B19-nutrients-09-00474]\]. In the current review, there were only three studies that provided an incentive and these studies did not have remarkably higher recruitment rates. Hence, more studies that do provide incentives are needed to elucidate whether or not incentives improve recruitment. Moreover, there are myriad reasons as to why somebody would or would not participate in a study. There are participant characteristics which in adults have been associated with a higher chance of non-participation such as younger age, being male, lower social economic status, and lower education level \[[@B154-nutrients-09-00474],[@B155-nutrients-09-00474]\]. However, in the limited number of studies on recruitment in children, no association between age or sex has been seen, although the education level of parents was associated with higher enrolment rates \[[@B5-nutrients-09-00474]\].

Beliefs about the effectiveness of the treatment may also play a role. Examples of reasons as to why adolescents did not participate informally given in Food2learn included: (1) the belief that *n*-3 LCPUFA are not effective in improving health; (2) the belief that they already consume sufficient amount of *n*-3 LCPUFA/already eat healthy; (3) the belief that participation will take too much time/effort; and (4) lack of interest in research in general. These factors should be taken into account during the research process and it seems wise to include explanations that most people do not get enough *n*-3 LCPUFA in their diet as well as elaborating on the possible health benefits of *n*-3 LCPUFA specific to the age group being assessed.

4.2. Adherence {#sec4dot2-nutrients-09-00474}
--------------

Just 25 studies mentioned a specific adherence percentage, which varied between 60% and 97% with a mean of 85%. Moreover, most studies included in the current review used indirect adherence assessment methods (i.e., diaries, interviews, and capsules counts) which are all subject to problems with reporting bias and errors or intentional manipulation \[[@B156-nutrients-09-00474]\]. More direct methods such as the determination of fatty acid levels in the blood seems to be the most reliable method to assess adherence, which was done in only five studies. However, it should be noted that taking blood samples in younger children might not be acceptable for all parents or ethical committees and could therefore lead to lower recruitment numbers.

In the current review, there was no difference in mean adherence in those studies where participants received a telephone call to try and increase adherence compared to those in which participants received no telephone call (M = 81.5% vs. M = 87.7%). There were only three studies that provided an incentive and only one of these studies provided an adherence percentage, which was 75%. There seemed to be a higher average adherence of capsules (M = 88.2%) compared to other forms of supplementation (M = 74.8%, M = 81.5%, M = 80.3%, for food, drink and other forms, respectively). Lastly, there was no difference in the mean adherence between those who took capsules multiple times a day compared to those who took capsules only once a day (M = 87.3% vs. M = 87.6%). It is however important to remember that all these findings are based on only 25 studies that mentioned an adherence rate.

Other studies suggest factors that are associated with higher adherence in children and adolescents, these include: sociodemographic factors (i.e., older children and older adolescents are less likely to be adherent, and boys are less likely to be adherent), disease associated factors (i.e., if the disease also has positive symptoms the person is less likely to be adherent), the belief and attitude that a person has towards the treatment (i.e., those that belief that the treatment will be effective are more likely to be adherent), their mood (i.e., those with depression are less likely to be adherent) and the social context (i.e., those who are supported by family and friends are more likely to be adherent) \[[@B157-nutrients-09-00474],[@B158-nutrients-09-00474]\]. Methods to increase adherence rates have also been suggested. Methods that have been employed to increase adherence include: educating participants about adherence, making medicine (or supplementation) more palatable, providing incentives/tokens, and involving parents or schools \[[@B159-nutrients-09-00474],[@B160-nutrients-09-00474]\]. However, one must take into consideration that the vast majority of studies looking at which methods can help increase adherence have been executed in a medical setting with patients requiring medications and these results do not by definition translate to nutritional interventions in healthy participants or those with diagnosed disorders such as ADHD.

Some suggestions for improving adherence for *n*-3 LCPUFA supplementation studies may include: providing sufficient information about the importance of adherence (i.e., explaining the importance of adherence to get valid results), getting parents involved, and providing appropriate incentives \[[@B159-nutrients-09-00474],[@B160-nutrients-09-00474]\].

4.3. Drop-Out {#sec4dot3-nutrients-09-00474}
-------------

In the current review, the average drop-out was 17% (range 0--58%). Three studies mentioned some form of incentive \[[@B98-nutrients-09-00474],[@B107-nutrients-09-00474],[@B146-nutrients-09-00474]\] and they reported a slightly lower average drop-out than those that did not use (or did not report) an incentive (M = 15.3% vs. M = 17.4%). There were differences in average drop-out rates between continents, with drop-out rates being higher in Australia (M = 34.9%), USA/Canada (M = 23.1%), and the Middle East (M = 20.1%) compared to Europe (M = 13.3%), Africa (M = 11.6%) and Asia (M = 6.8%). We can only speculate about explanations for this difference (e.g., individualistic vs. collective societies) and do point out that these differences have to be interpreted with caution as the number of studies per continent did differ greatly. A number of methods to decrease drop-out in studies involving adults has been suggested. They include emphasizing the benefit of participation, flexible scheduling of appointments, regular positive communication from the research team to the participants (e.g., birthday and Christmas cards, newsletters, etc.), a consistent research staff so participants can build a bond with the researchers, and appropriate incentives \[[@B150-nutrients-09-00474],[@B161-nutrients-09-00474],[@B162-nutrients-09-00474],[@B163-nutrients-09-00474]\]. Other strategies that have been suggested include decreasing the complexity of the treatment and limiting the number of follow-up visits to the bare minimum \[[@B164-nutrients-09-00474]\]. Furthermore, a combination of multiple strategies is suggested to be most effective in increasing retention \[[@B161-nutrients-09-00474],[@B164-nutrients-09-00474]\]. All these methods to decrease drop-out have been studied in adults; more research on methods to decrease drop-out in children and adolescents in RCT is warranted.

Suggestions for decreasing drop-out in *n*-3 LCPUFA supplementation trial include: keeping in regular contact with the participants, providing flexible appointment possibilities, providing incentives for participants and providing reminders. With regard to the supplement, one should keep the regime as simple as possible e.g., one (concentrated) capsule per day \[[@B150-nutrients-09-00474],[@B161-nutrients-09-00474],[@B162-nutrients-09-00474],[@B163-nutrients-09-00474],[@B164-nutrients-09-00474]\].

4.4. Strengths and Limitations {#sec4dot4-nutrients-09-00474}
------------------------------

Limitations of the current review include the fact that many of the included studies did not report all data on recruitment, dropout and (assessment of) adherence. Due to the incomplete reporting of data, results should be viewed with caution. The main advantage of the current review is the fact that we included all studies investigating *n*-3 LCPUFA supplementation in children/adolescents regardless of whether they were healthy children/adolescents or children/adolescents with a disease or disorder.

5. Conclusions {#sec5-nutrients-09-00474}
==============

The conclusions drawn are based on minimal reporting from the included studies in this review. Less than half of the included studies abided by the CONSORT guidelines. Problems with recruitment and drop-out seem to be common in *n*-3 LCPUFA supplementation trials in children and adolescents. However, since the reporting about recruitment, adherence and dropout rates was very heterogeneous and minimal in the included studies, we cannot provide specific suggestions to improve LCPUFA supplementation studies in children and adolescents.

6. Recommendations {#sec6-nutrients-09-00474}
==================

It is important for future studies to report on recruitment effort and rate, adherence (including the method of assessing adherence) and drop-out rates according to the CONSORT Guidelines.

Suggestions from other scientific areas to increase recruitment, adherence and minimize drop-out include: the provision of sufficient information about the importance of adherence (i.e., explaining the importance of adherence to get valid results), getting parents involved, provision of appropriate incentives, emphasizing the benefit of participation, being flexible with the scheduling of appointments, the research team engaging in regular positive communication with the participants, having a consistent research staff member so participants can build a bond with the researchers and to keep the supplementation regime as simple as possible.
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###### 

Characteristics of studies.

  Reference                                                                                                         Age Range or Mean (SD)                    Gender (%Female)            Population: Healthy, Disorder or Disease   Country
  ----------------------------------------------------------------------------------------------------------------- ----------------------------------------- --------------------------- ------------------------------------------ -------------------------
  \[[@B58-nutrients-09-00474]\]                                                                                     3--15                                     44                          Acute lymphoblastic leukemia               Egypt
  \[[@B59-nutrients-09-00474]\]                                                                                     6--12                                     25                          ADHD                                       Iran
  \[[@B60-nutrients-09-00474]\]                                                                                     7--15                                     NR                          ADHD                                       Iran
  \[[@B61-nutrients-09-00474]\]                                                                                     11--12                                    31                          ADHD                                       Canada
  \[[@B62-nutrients-09-00474]\]                                                                                     8--14                                     0                           ADHD                                       The Netherlands
  \[[@B63-nutrients-09-00474]\]                                                                                     6--16                                     41 (after intervention)     ADHD                                       Israel
  \[[@B64-nutrients-09-00474]\]                                                                                     7--12                                     20                          ADHD                                       Sweden
  \[[@B65-nutrients-09-00474]\]                                                                                     6--12                                     38                          ADHD                                       Iran
  \[[@B66-nutrients-09-00474]\]                                                                                     6--12                                     NR                          ADHD                                       Japan
  \[[@B67-nutrients-09-00474],[@B68-nutrients-09-00474]\]                                                           8--18                                     15                          ADHD                                       Sweden
  \[[@B69-nutrients-09-00474]\]                                                                                     12--16                                    0                           ADHD                                       UK
  \[[@B70-nutrients-09-00474],[@B71-nutrients-09-00474]\]                                                           6--13                                     23                          ADHD                                       Australia
  \[[@B72-nutrients-09-00474]\]                                                                                     6--12                                     27                          ADHD                                       Sri Lanka
  \[[@B73-nutrients-09-00474]\]                                                                                     7--13                                     41                          ADHD                                       Israel
  \[[@B74-nutrients-09-00474],[@B75-nutrients-09-00474]\]                                                           7--12                                     23                          ADHD                                       Australia
  \[[@B76-nutrients-09-00474]\]                                                                                     6--13                                     13                          ADHD                                       USA
  \[[@B77-nutrients-09-00474]\]                                                                                     8--13                                     25                          ADHD                                       Israel
  \[[@B78-nutrients-09-00474]\]                                                                                     6--12                                     22                          ADHD                                       USA
  \[[@B79-nutrients-09-00474]\]                                                                                     6--12                                     22                          ADHD                                       Germany
  \[[@B80-nutrients-09-00474],[@B81-nutrients-09-00474]\]                                                           6--13                                     34                          ADHD                                       Israel
  \[[@B82-nutrients-09-00474]\]                                                                                     7--12                                     43 (after intervention)     ADHD or lower IQ                           China
  \[[@B83-nutrients-09-00474]\]                                                                                     6--14                                     15                          ADHD                                       Australia
  \[[@B84-nutrients-09-00474]\]                                                                                     6.9--11.9                                 NR                          ADHD                                       Canada
  \[[@B85-nutrients-09-00474]\]                                                                                     8--16                                     48                          Aggressive behaviour                       Mauritius
  \[[@B86-nutrients-09-00474]\]                                                                                     6--14                                     42                          Asthma                                     USA
  \[[@B87-nutrients-09-00474]\]                                                                                     8--12                                     56                          Asthma                                     Australia
  \[[@B88-nutrients-09-00474]\]                                                                                     10--12                                    31                          Asthma                                     Taiwan
  \[[@B89-nutrients-09-00474]\]                                                                                     10.2 (2.5) fish oil, 11.9 (3.1) control   48                          Bronchial asthma                           Japan
  \[[@B90-nutrients-09-00474]\]                                                                                     3--8                                      11                          Autism                                     USA
  \[[@B91-nutrients-09-00474]\]                                                                                     5--8                                      NR                          Autism                                     USA
  \[[@B92-nutrients-09-00474]\]                                                                                     2--5                                      26                          Autism                                     Canada
  \[[@B93-nutrients-09-00474]\]                                                                                     3--10                                     17                          Autism                                     USA
  \[[@B94-nutrients-09-00474]\]                                                                                     6--17                                     48% placebo, 46% flax oil   Bipolar disorder                           USA
  \[[@B95-nutrients-09-00474]\]                                                                                     7.3--9.5                                  54                          CF                                         Italy
  \[[@B96-nutrients-09-00474]\]                                                                                     5--16                                     47                          Crohn's disease                            Italy
  \[[@B97-nutrients-09-00474]\]                                                                                     5--12                                     33                          DCD                                        UK
  \[[@B98-nutrients-09-00474]\]                                                                                     10.6                                      43                          Dyslexia                                   Finland
  \[[@B99-nutrients-09-00474]\]                                                                                     15--18                                    100                         Dysmenorrhea                               USA
  \[[@B100-nutrients-09-00474]\]                                                                                    4--12                                     NR                          Epilepsy                                   Egypt
  \[[@B101-nutrients-09-00474]\]                                                                                    7--9                                      53                          Healthy                                    South-Africa
  \[[@B102-nutrients-09-00474]\]                                                                                    8--14                                     50                          Healthy                                    Indonesia
  \[[@B103-nutrients-09-00474]\]                                                                                    9--12                                     51                          Healthy                                    Japan
  \[[@B104-nutrients-09-00474]\]                                                                                    9--10                                     50                          Healthy                                    Sweden
  \[[@B105-nutrients-09-00474]\]                                                                                    10--12                                    49                          Healthy                                    UK
  \[[@B106-nutrients-09-00474]\]                                                                                    8--10                                     52                          Healthy                                    UK
  \[[@B107-nutrients-09-00474]\]                                                                                    5--7                                      NR                          Healthy                                    Canada
  \[[@B108-nutrients-09-00474]\]                                                                                    8--10                                     0                           Healthy                                    USA
  \[[@B109-nutrients-09-00474]\]                                                                                    6--10                                     46                          Healthy                                    Australia and Indonesia
  \[[@B110-nutrients-09-00474]\]                                                                                    3--13                                     46                          Healthy                                    Australia
  \[[@B111-nutrients-09-00474]\]                                                                                    8--14                                     51                          Healthy                                    Spain
  \[[@B112-nutrients-09-00474]\]                                                                                    4                                         47                          Healthy                                    USA
  \[[@B113-nutrients-09-00474]\]                                                                                    10--12                                    100                         Healthy                                    Turkey
  \[[@B114-nutrients-09-00474]\]                                                                                    13--16                                    50                          Healthy                                    UK
  \[[@B115-nutrients-09-00474]\]                                                                                    9--12                                     47                          Healthy                                    Thailand
  \[[@B116-nutrients-09-00474]\]                                                                                    8--13                                     47                          Hyperlipidaemia                            Italy
  \[[@B117-nutrients-09-00474]\]                                                                                    14 (2)                                    31                          Hypertriglyceridemia and low LDL           USA
  \[[@B118-nutrients-09-00474],[@B119-nutrients-09-00474],[@B120-nutrients-09-00474],[@B121-nutrients-09-00474]\]   6--11                                     49                          Iron deficiency                            South-Africa
  \[[@B122-nutrients-09-00474]\]                                                                                    8--12                                     15                          Literacy problems                          UK
  \[[@B123-nutrients-09-00474]\]                                                                                    8--12                                     58                          Malnourished                               Mexico
  \[[@B124-nutrients-09-00474]\]                                                                                    5--14                                     56                          Migraine                                   Iran
  \[[@B125-nutrients-09-00474]\]                                                                                    7--14                                     NR                          MDD                                        USA
  \[[@B126-nutrients-09-00474]\]                                                                                    6--12                                     NR                          MDD                                        Israel
  \[[@B127-nutrients-09-00474]\]                                                                                    10--18                                    59 (after intervention)     Metabolic syndrome                         Iran
  \[[@B128-nutrients-09-00474]\]                                                                                    9--17                                     47                          NAFL and obesity                           Turkey
  \[[@B129-nutrients-09-00474],[@B130-nutrients-09-00474]\]                                                         11--15                                    14                          NAFL and overweight                        Poland
  \[[@B131-nutrients-09-00474],[@B132-nutrients-09-00474],[@B133-nutrients-09-00474]\]                              6--16                                     58                          NAFL                                       Italy
  \[[@B134-nutrients-09-00474]\]                                                                                    10.8 (2.8)                                48                          NAFL and overweight                        Italy
  \[[@B135-nutrients-09-00474]\]                                                                                    8--18                                     0                           NAFL                                       Canada
  \[[@B136-nutrients-09-00474],[@B137-nutrients-09-00474]\]                                                         14--17                                    56                          Obesity                                    Sweden
  \[[@B138-nutrients-09-00474],[@B139-nutrients-09-00474]\]                                                         13--15                                    0                           Overweight                                 Denmark
  \[[@B140-nutrients-09-00474]\]                                                                                    9--18                                     NR                          Overweight + insulin resistance            Mexico
  \[[@B141-nutrients-09-00474]\]                                                                                    5--10                                     NR                          PKU                                        Italy
  \[[@B142-nutrients-09-00474]\]                                                                                    6--18                                     18                          Tourette's Disorder                        USA
  \[[@B143-nutrients-09-00474],[@B144-nutrients-09-00474],[@B145-nutrients-09-00474]\]                              10 (7)                                    45                          Type-1 type-1 hyperphenylalaninemia, HPA   Italy
  \[[@B146-nutrients-09-00474],[@B147-nutrients-09-00474]\]                                                         6--10                                     47                          Underperforming                            UK

ADHD = attention deficit hyperactivity disorder; NAFL = non-alcoholic fatty liver; MDD = major depressive disorder; DCD = Developmental Co-ordination Disorder; CF = cystic fibrosis, NR = not reported.
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###### 

Treatment characteristics per study.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference                                                                                                         Treatment per Day Unless Otherwise Stated                                          Placebo                                                                        Form of Supplementation                  Number of Capsules       Duration ^b^ (Weeks)
  ----------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------- ------------------------------------------------------------------------------ ---------------------------------------- ------------------------ ------------------------------------------
  \[[@B108-nutrients-09-00474]\]                                                                                    DHASCO ^a^: 400 or 1200 mg DHA                                                     Corn oil                                                                       Capsules                                 6                        8

  \[[@B106-nutrients-09-00474]\]                                                                                    800 mg FO: 400 mg DHA, 56 mg EPA                                                   Olive oil                                                                      Chewable capsules                        2                        16

  \[[@B113-nutrients-09-00474]\]                                                                                    670 mg FO                                                                          Olive oil                                                                      Capsules                                 2                        16

  \[[@B110-nutrients-09-00474]\]                                                                                    2400 mg FO and 600 mg evening primrose oil: 174 mg DHA, 558 mg EPA, 60 mg GLA.     Palm oil                                                                       Capsules                                 6                        28.6

  \[[@B104-nutrients-09-00474]\]                                                                                    174 mg DHA, 558 mg EPA, 60 mg GLA                                                  Palm oil                                                                       Capsules                                 6                        12 + 12 (open)

  \[[@B102-nutrients-09-00474]\]                                                                                    1260 mg DHA rich oil: 652 mg DHA, 101 mg EPA                                       Placebo oil (656 mg LA, 87 mg ALA)                                             Capsules                                 6                        12

  \[[@B101-nutrients-09-00474]\]                                                                                    Fish flour: 892 mg of DHA per week                                                 Placebo spread contained bread flour                                           Margarine                                NA                       14.9

  \[[@B107-nutrients-09-00474]\]                                                                                    14--21 mg DHA, 20--30 mg AA                                                        Placebo supplement                                                             Sachets to mix into foods                2--3 sachets             30

  \[[@B103-nutrients-09-00474]\]                                                                                    FO: 3600 mg DHA, 840 mg EPA per week                                               50% soybean oil, 50% rapeseed oil (4200 mg LA per week)                        Bread and sausages                       NA                       12

  \[[@B114-nutrients-09-00474]\]                                                                                    541 mg FO: 116 mg DHA, 165 mg EPA                                                  Sunflower oil                                                                  Capsules                                 2                        12

  \[[@B112-nutrients-09-00474]\]                                                                                    DHASCO-S ^a^: 400 mg DHA                                                           High oleic sunflower oil                                                       Capsules                                 2                        16

  \[[@B115-nutrients-09-00474]\]                                                                                    FO: 1 g DHA, 200 mg EPA                                                            Soybean oil                                                                    Chocolate milk                           NA                       15.6

  \[[@B109-nutrients-09-00474]\]                                                                                    88 mg DHA, 22 mg EPA                                                               Unclear                                                                        Drink                                    NA                       52

  \[[@B105-nutrients-09-00474]\]                                                                                    500 mg DHASCO-S ^a^: 200 mg DHA, 4 mg EPA                                          Vegetable oil (15 mg ALA, 250 mg LA)                                           Capsules                                 5                        8

  \[[@B111-nutrients-09-00474]\]                                                                                    FO in dairy drink 120 mg DHA, 60 mg EPA                                            Whole milk                                                                     Milk drink                               NA                       20

  \[[@B117-nutrients-09-00474]\]                                                                                    4 g FO: 1.5 g DHA, 1.86 g EPA                                                      Corn oil                                                                       Unclear                                  Unclear                  8 + 8 with 4 weeks wash-out in between

  \[[@B100-nutrients-09-00474]\]                                                                                    3 mL dose of 1200 mg FO: 240 mg DHA, 360 mg EPA.                                   Corn oil                                                                       Liquid oil                               NA                       12

  \[[@B88-nutrients-09-00474]\]                                                                                     FO: 125 mg DHA, 230 mg EPA                                                         Corn oil                                                                       Capsules                                 Dependent on bw          16

  \[[@B96-nutrients-09-00474]\]                                                                                     3 g O3FA                                                                           Olive oil                                                                      Capsules                                 Dependent on bw          52

  \[[@B92-nutrients-09-00474]\]                                                                                     1.875 mL FO: 0.75 g of DHA + EPA. If well tolerated dose ×2 after 2 weeks.         Olive oil and medium chain triglycerides.                                      Liquid oil                               NA                       24

  \[[@B65-nutrients-09-00474]\]                                                                                     165 mg DHA, 635 mg EPA, 100 mg other O3FA                                          Olive oil                                                                      Capsules                                 NS                       8

  \[[@B67-nutrients-09-00474],[@B68-nutrients-09-00474]\]                                                           174 mg DHA, 558 mg EPA, 60 mg GLA                                                  Olive oil                                                                      Capsules                                 6                        12 + 12 (open)

  \[[@B97-nutrients-09-00474]\]                                                                                     FO and EPO: 174 mg DHA, 558 mg EPA, 60 mg GLA                                      Olive oil                                                                      Capsules                                 6                        26

  \[[@B79-nutrients-09-00474]\]                                                                                     120 mg DHA, 600 mg EPA                                                             Olive oil                                                                      Capsules                                 2                        16

  \[[@B122-nutrients-09-00474]\]                                                                                    480 mg DHA, 186 mg EPA, 96 mg GLA, 864 mg LA, 42 mg AA, 8 mg thyme oil             Olive oil                                                                      Capsules                                 NR                       12

  \[[@B66-nutrients-09-00474]\]                                                                                     DHA-rich fish oil: 3600 mg DHA 700 mg EPA per week.                                Olive oil                                                                      Milk and bread                           NA                       12

  \[[@B76-nutrients-09-00474]\]                                                                                     480 mg DHA, 80 mg EPA, 40 mg AA, 96 mg GLA                                         Olive oil                                                                      Capsules                                 8                        16

  \[[@B143-nutrients-09-00474],[@B144-nutrients-09-00474],[@B145-nutrients-09-00474]\]                              LCPUFA supplementation: varying dosage                                             Olive oil                                                                      Capsules                                 1 per 4 kg of bw         52

  \[[@B94-nutrients-09-00474]\]                                                                                     Flax seed oil: 0.55 to 6.6 g ALA                                                   Olive oil                                                                      Capsules                                 Varying up to 12         16

  \[[@B89-nutrients-09-00474]\]                                                                                     FO: DHA 7.3 ± 11.5 mg/kg of bw, EPA 17.0 ± 26.8 mg/kg of bw                        Olive oil                                                                      Capsules                                 Dependent on bw: 6--12   43.6

  \[[@B83-nutrients-09-00474]\]                                                                                     PCSO-524 ^c^: 16.5--22 mg DHA, 21.9--29.2 mg EPA                                   Olive oil, lecithin and coconut oil                                            Capsules                                 Dependent on bw: 3--4    14

  \[[@B86-nutrients-09-00474]\]                                                                                     Drink containing FO (1.6 g DHA, 3 g EPA) and borage oil (3.0 g GLA)                Control drink with high oleic safflower oil                                    Drink                                    NA                       12

  \[[@B70-nutrients-09-00474]\]                                                                                     EPA-rich FO: 108 mg DHA, 1,109 mg EPA or DHA-rich FO: 1,032 mg DHA, 264 mg EPA     Safflower oil                                                                  Capsules                                 4                        16 + 16 + 16

  \[[@B90-nutrients-09-00474]\]                                                                                     FO: 1.1 g DHA + EPA                                                                Safflower oil                                                                  Pudding packet                           2 pudding packs          12

  \[[@B123-nutrients-09-00474]\]                                                                                    FO: 180 mg DHA, 270 mg EPA                                                         Soybean oil                                                                    Capsules                                 3                        12

  \[[@B135-nutrients-09-00474]\]                                                                                    2 g FO: 1200 mg DHA + EPA                                                          Sunflower oil                                                                  Capsules                                 4                        24

  \[[@B87-nutrients-09-00474]\]                                                                                     FO: 1.2 g O3FA                                                                     Sunflower oil                                                                  Capsules, salad dressing and margarine   4                        24

  \[[@B72-nutrients-09-00474]\]                                                                                     FO and EPO oil: 592.74 mg O3FA                                                     Sunflower oil                                                                  Capsules                                 2                        26

  \[[@B58-nutrients-09-00474]\]                                                                                     1 g FO:120 mg DHA, 180 mg EPA                                                      Sunflower oil                                                                  Capsules                                 Unclear                  24

  \[[@B61-nutrients-09-00474]\]                                                                                     100--400 mg DHA, 500--100 mg EPA                                                   Sunflower oil                                                                  Capsules                                 Dependent on bw: 2--4    16

  \[[@B129-nutrients-09-00474],[@B130-nutrients-09-00474]\]                                                         AO: 450--1300 mg O3FA (DHA: EPA in 3:2 proportion)                                 Sunflower oil                                                                  Capsules                                 Dependent on bw          24

  \[[@B116-nutrients-09-00474]\]                                                                                    AO: 500 mg DHA or FO:500 mg DHA + EPA                                              Wheat gern oil                                                                 Capsules                                 1                        16

  \[[@B131-nutrients-09-00474],[@B132-nutrients-09-00474],[@B133-nutrients-09-00474]\]                              AO: 250 or 500 mg DHA                                                              Germ oil                                                                       Capsules                                 1                        26.1

  \[[@B134-nutrients-09-00474]\]                                                                                    AO: 250 mg DHA                                                                     Germ oil                                                                       Capsules                                 NR                       26

  \[[@B95-nutrients-09-00474]\]                                                                                     Algae triacylglycerol 100 mg DHA/kg/day 1st month then 1 g DHA/day                 Germ oil                                                                       Capsules                                 4                        52

  \[[@B93-nutrients-09-00474]\]                                                                                     AO: 200 mg DHA                                                                     Corn oil + soy bean oil                                                        Capsules                                 1                        26

  \[[@B146-nutrients-09-00474],[@B147-nutrients-09-00474]\]                                                         AO: 600 mg DHA                                                                     Corn oil + soy oil                                                             Capsules                                 3                        16

  \[[@B138-nutrients-09-00474],[@B139-nutrients-09-00474]\]                                                         4.9 g FO: 892 mg DHA, 191 mg EPA                                                   6:1:1 mix of palm shortening, soy oil, and rapeseed oil                        Bread                                    NA                       16

  \[[@B141-nutrients-09-00474]\]                                                                                    2.5--4 g FO (12% DHA, 18% EPA)                                                     Blackcurrant seed oil (45.7% LA, 18% GLA, 14% ALA)                             Capsules                                 Dependent on bw: 5-8     26

  \[[@B62-nutrients-09-00474]\]                                                                                     650 mg DHA, 650 mg EPA                                                             Normal margarine (1 g LA)                                                      Margarine                                NA                       16

  \[[@B99-nutrients-09-00474]\]                                                                                     FO: 720 mg DHA, 1080 mg EPA                                                        1800mg lactose                                                                 Capsules                                 2                        8+8

  \[[@B125-nutrients-09-00474]\]                                                                                    200 mg DHA, 1400 mg EPA, 400 mg other O3FA                                         Placebo capsule                                                                Capsules                                 2                        12

  \[[@B136-nutrients-09-00474],[@B137-nutrients-09-00474]\]                                                         FO and EPO: 290 mg DHA, 930 mg EPA, 100 mg GLA                                     Placebo                                                                        Capsules                                 10                       12 + 12 with 6 weeks wash-out in between

  \[[@B91-nutrients-09-00474]\]                                                                                     FO: 1.1 g DHA + EPA                                                                Identical placebo                                                              Pudding packet                           2 pudding packs          6

  \[[@B128-nutrients-09-00474]\]                                                                                    1000 mg PUFA                                                                       Placebo                                                                        Capsule                                  1                        52

  \[[@B63-nutrients-09-00474]\]                                                                                     2 g sage oil: 1 g ALA                                                              Lactose placebo                                                                Capsules                                 2                        8

  \[[@B60-nutrients-09-00474]\]                                                                                     240 mg DHA, 360 mg EPA                                                             Placebo                                                                        Capsules                                 2                        8

  \[[@B64-nutrients-09-00474]\]                                                                                     FO: 2.7 mg DHA, 500 mg EPA                                                         Placebo                                                                        Capsules                                 1                        15

  \[[@B127-nutrients-09-00474]\]                                                                                    2.4 g omega-3                                                                      Vitamin E or placebo                                                           Tablets                                  NR                       8

  \[[@B84-nutrients-09-00474]\]                                                                                     100 mg DHA, 250 mg EPA, 25 mg phospholipids                                        Sunflower oil                                                                  Capsules                                 According to bw: 1--2    16

  \[[@B124-nutrients-09-00474]\]                                                                                    1 g FO: 120 mg DHA, 180 mg EPA                                                     Placebo capsule                                                                Capsules                                 1                        At least 8 weeks

  \[[@B78-nutrients-09-00474]\]                                                                                     Algae oil: 345 mg DHA                                                              Placebo capsule                                                                Capsules                                 1                        16

  \[[@B59-nutrients-09-00474]\]                                                                                     241 mg DHA, 33 mg EPA, and 180 mg omega-6                                          Identical placebo                                                              Capsules                                 1                        10

  \[[@B118-nutrients-09-00474],[@B119-nutrients-09-00474],[@B120-nutrients-09-00474],[@B121-nutrients-09-00474]\]   FO: 155 mg DHA, 29 mg EPA                                                          Placebo                                                                        Capsules                                 2                        15

  \[[@B142-nutrients-09-00474]\]                                                                                    Varying 500--6000 mg O3FA                                                          Placebo                                                                        Capsules                                 Varying up to 12         20

  \[[@B140-nutrients-09-00474]\]                                                                                    Salmon oil: 360 mg DHA, 540 mg EPA                                                 Placebo (corn starch, lactose, magnesium stearate and polyvinyl pyrrolidone)   Capsules                                 NR                       4

  \[[@B85-nutrients-09-00474]\]                                                                                     300 mg DHA, 200 mg EPA, 400 mg ALA, 100 mg of DPA                                  Drink without omega-3                                                          Drink                                    NA                       24

  \[[@B77-nutrients-09-00474]\]                                                                                     FO: 96 mg DHA, 153 mg EPA or *n*-3 LC-PUFA containing PLs: 95 mg DHA, 156 mg EPA   Rapeseed oil                                                                   Chocolate flavoured spread               NA                       13.1

  \[[@B73-nutrients-09-00474]\]                                                                                     240 mg LA, 60 mg ALA, 95 mg mineral oil                                            Vitamine C capsules                                                            Capsules                                 1                        7

  \[[@B69-nutrients-09-00474]\]                                                                                     FO and EPO: 174 mg DHA, 558 mg EPA, 60 mg LA.                                      Medium chain triglycerides                                                     Capsules                                 6                        12

  \[[@B126-nutrients-09-00474]\]                                                                                    200 mg DHA 400 mg EPA, or 180 mg DHA, 380 mg EPA                                   Olive oil or safflower oil                                                     Capsules                                 1--2                     16

  \[[@B74-nutrients-09-00474],[@B75-nutrients-09-00474]\]                                                           FO and EPO: 174 mg DHA, 558 mg EPA, 60 mg GLA                                      Palm oil                                                                       Capsules                                 6                        30

  \[[@B98-nutrients-09-00474]\]                                                                                     500 mg ethyl-EPA                                                                   Triglycerides and cellulose                                                    Capsules                                 NR                       12.9

  \[[@B80-nutrients-09-00474],[@B81-nutrients-09-00474]\]                                                           1--15 weeks: 120 mg EPA + DHA\                                                     Cellulose                                                                      Capsules                                 4                        15 + 15
                                                                                                                    16--30 weeks: 60 mg EPA + DHA                                                                                                                                                                                                       

  \[[@B82-nutrients-09-00474]\]                                                                                     321 mg DHA, 42.2 g EPA per 100 g egg                                               Ordinary egg                                                                   Egg                                      1                        13.1
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^ DHASCO is an algal triglyceride DHA; ^b^ Some studies gave duration in months or number of days supplementation was received, we recalculated the duration to weeks; ^c^ PCSO-524 is an lipid extract of the New Zealand green-lipped mussel; bw: body weight, NA: not appropriate, NR: not reported.
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###### 

Recruitment effort and recruitment rates.

  Reference                                                                                                         Invited   Responded/Screened   Started   Finished   Started/Invited %   Started/Responded %   Started/Finished %   Recruitment Method                                                                                                                                                                     Recruitment Setting                                         Study Period
  ----------------------------------------------------------------------------------------------------------------- --------- -------------------- --------- ---------- ------------------- --------------------- -------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------- -------------------------------------
  \[[@B141-nutrients-09-00474]\]                                                                                    NS        NS                   21        21         \-                  \-                    100                  NS                                                                                                                                                                                     Department of Paediatrics                                   NS
  \[[@B66-nutrients-09-00474]\]                                                                                     46        40                   40        40         87                  100                   100                  Parents of summer camp participants were asked.                                                                                                                                        Summer camp for children with psychiatric disorders         NS
  \[[@B98-nutrients-09-00474]\]                                                                                     107       107                  61        61         57                                        100                  Teachers nominated children with reading difficulties                                                                                                                                  School                                                      Autumn 2005--January 2006
  \[[@B131-nutrients-09-00474],[@B132-nutrients-09-00474],[@B133-nutrients-09-00474]\]                              NS        NS                   60        60         \-                  \-                    100                  NS                                                                                                                                                                                     Hospital                                                    NS
  \[[@B115-nutrients-09-00474]\]                                                                                    NS        NS                   180       180        \-                  \-                    100                  NS                                                                                                                                                                                     School                                                      NS
  \[[@B116-nutrients-09-00474]\]                                                                                    NS        NS                   36        36         \-                  \-                    100                  NS                                                                                                                                                                                     Hospital                                                    8 month period
  \[[@B146-nutrients-09-00474],[@B147-nutrients-09-00474]\]                                                         1376      675                  362       359        26                  54                    99                   Parents of underperforming children received a letter inviting their children to take part in the formal screening assessments.                                                        School                                                      NS
  \[[@B105-nutrients-09-00474]\]                                                                                    NS        NS                   90        88         \-                  \-                    98                   Via advertising in newspapers and schools                                                                                                                                              Community and schools                                       NS
  \[[@B88-nutrients-09-00474]\]                                                                                     NS        298                  197       192        \-                  66                    98                   Participants with asthma diagnosis were recruited from elementary schools through parent conferences                                                                                   Schools                                                     NS
  \[[@B82-nutrients-09-00474]\]                                                                                     1556      1556                 179       171        12                  12                    96                   Children were screened from students in two township primary schools                                                                                                                   Schools                                                     NS
  \[[@B62-nutrients-09-00474]\]                                                                                     NS        372                  79        76         \-                  21                    96                   Via hospital and advertising at schools.                                                                                                                                               Hospital and schools                                        NS
  \[[@B72-nutrients-09-00474]\]                                                                                     NS        422                  98        94         \-                  23                    96                   NS                                                                                                                                                                                     Outpatient treatment program                                NS
  \[[@B114-nutrients-09-00474]\]                                                                                    NS        408                  196       189        \-                  48                    96                   NS                                                                                                                                                                                     School                                                      NS
  \[[@B58-nutrients-09-00474]\]                                                                                     NS        100                  70        65         \-                  70                    93                   NS                                                                                                                                                                                     Hospital                                                    NS
  \[[@B117-nutrients-09-00474]\]                                                                                    NS        NS                   42        39         \-                  \-                    93                   NS                                                                                                                                                                                     Hospital                                                    NS
  \[[@B118-nutrients-09-00474],[@B119-nutrients-09-00474],[@B120-nutrients-09-00474],[@B121-nutrients-09-00474]\]   NS        926                  321       294        \-                  35                    92                   Parents were invited to an information meeting.                                                                                                                                        School                                                      November 2009--November 2010
  \[[@B127-nutrients-09-00474]\]                                                                                    NS        NS                   90        83         \-                  \-                    92                   NS                                                                                                                                                                                     Cardiovascular Research Centre                              NS
  \[[@B60-nutrients-09-00474]\]                                                                                     NS        NS                   75        69         \-                  \-                    92                   NS                                                                                                                                                                                     Outpatient ADHD clinic                                      2007
  \[[@B103-nutrients-09-00474]\]                                                                                    NS        230                  179       166        \-                  78                    92                   Via advertisements                                                                                                                                                                     Community                                                   NS
  \[[@B85-nutrients-09-00474]\]                                                                                     NS        938                  200       184        \-                  21                    92                   Via parents who themselves had participated in a study.                                                                                                                                Participants earlier study                                  November 2009--December 2011
  \[[@B123-nutrients-09-00474]\]                                                                                    NS        59                   55        50         \-                  93                    91                   Parents were invited to a meeting at which the study procedures were explained and a written informed consent from the tutors and a verbal assent from their children were obtained.   School                                                      NS
  \[[@B95-nutrients-09-00474]\]                                                                                     NS        NS                   41        37         \-                  \-                    90                   NS                                                                                                                                                                                     Hospital                                                    NS
  \[[@B101-nutrients-09-00474]\]                                                                                    NS        NS                   183       164        \-                  \-                    90                   NS                                                                                                                                                                                     School                                                      NS
  \[[@B138-nutrients-09-00474],[@B139-nutrients-09-00474]\]                                                         3652      NS                   87        78         2                   \-                    90                   Subjects were recruited via addresses obtained from the Danish Civilian Person Register.                                                                                               Community                                                   NS
  \[[@B111-nutrients-09-00474]\]                                                                                    NS        NS                   119       107        \-                  \-                    90                   NS                                                                                                                                                                                     School                                                      NS
  \[[@B99-nutrients-09-00474]\]                                                                                     NS        NS                   42        37         \-                  \-                    88                   NS                                                                                                                                                                                     School                                                      NS
  \[[@B134-nutrients-09-00474]\]                                                                                    NS        118                  58        51         \-                  49                    88                   NS                                                                                                                                                                                     Hospital                                                    May 2012--September 2014
  \[[@B113-nutrients-09-00474]\]                                                                                    NS        44                   33        29         \-                  75                    88                   Via public flyers                                                                                                                                                                      Community                                                   NS
  \[[@B135-nutrients-09-00474]\]                                                                                    NS        30                   24        21         \-                  80                    88                   NS                                                                                                                                                                                     Hospital                                                    NS
  \[[@B87-nutrients-09-00474]\]                                                                                     NS        NS                   45        39         \-                  \-                    87                   NS                                                                                                                                                                                     NS                                                          Over period of 16 mo.
  \[[@B108-nutrients-09-00474]\]                                                                                    NS        48                   38        33         \-                  79                    87                   NS                                                                                                                                                                                     NS                                                          NS
  \[[@B112-nutrients-09-00474]\]                                                                                    NS        405                  202       175        \-                  50                    87                   NS                                                                                                                                                                                     NS                                                          NS
  \[[@B86-nutrients-09-00474]\]                                                                                     NS        NS                   43        37         \-                  \-                    86                   NS                                                                                                                                                                                     Outpatient clinic                                           NS
  \[[@B65-nutrients-09-00474]\]                                                                                     NS        NS                   120       103        \-                  \-                    86                   NS                                                                                                                                                                                     Hospital                                                    NS
  \[[@B97-nutrients-09-00474]\]                                                                                     189       129                  117       100        62                  91                    86                   Letters of invitation were sent to parents of children who were identified by teachers.                                                                                                School                                                      NS
  \[[@B78-nutrients-09-00474]\]                                                                                     NS        250                  63        54         \-                  25                    86                   Via advertisements                                                                                                                                                                     Community                                                   NS
  \[[@B79-nutrients-09-00474]\]                                                                                     NS        334                  110       95         \-                  33                    86                   Via health professionals, teachers, leaflets handed out to support groups, leaflet distributed at community centres and advertisements in a free of charge regional newspaper.         Community, Health professionals, schools, support groups.   NS
  \[[@B64-nutrients-09-00474]\]                                                                                     NS        NS                   109       92         \-                  \-                    84                   NS                                                                                                                                                                                     Hospital and secondary treatment centres                    January 2005--June 2007.
  \[[@B129-nutrients-09-00474],[@B130-nutrients-09-00474]\]                                                         NS        86                   76        64         \-                  88                    84                   NS                                                                                                                                                                                     Hospital                                                    2008-2011
  \[[@B92-nutrients-09-00474]\]                                                                                     NS        101                  38        32         \-                  38                    84                   NS                                                                                                                                                                                     Hospital                                                    December 2010--December 2013
  \[[@B107-nutrients-09-00474]\]                                                                                    NS        NS                   37        31         \-                  \-                    84                   NS                                                                                                                                                                                     NS                                                          NS
  \[[@B143-nutrients-09-00474],[@B144-nutrients-09-00474],[@B145-nutrients-09-00474]\]                              NS        NS                   24        20         \-                  \-                    83                   NS                                                                                                                                                                                     NS                                                          Recruited over 6 month
  \[[@B125-nutrients-09-00474]\]                                                                                    NS        178                  23        19         \-                  13                    83                   Via advertisements and clinician referrals.                                                                                                                                            Community and referral                                      July 2011--May 2014
  \[[@B109-nutrients-09-00474]\]                                                                                    NS        932                  780       643        \-                  84                    82                   Via advertisement at schools and media advertisement.                                                                                                                                  Schools                                                     Auguet 2003--April 2005
  \[[@B136-nutrients-09-00474],[@B137-nutrients-09-00474]\]                                                         108       47                   31        25         29                  66                    81                   NS.                                                                                                                                                                                    Outpatient clinic                                           NS
  \[[@B73-nutrients-09-00474]\]                                                                                     NS        \~300                78        63         \-                  26                    81                   Via advertisement on radio health program, in health newspapers and in ADHD clinics.                                                                                                   Community and ADHD clinic                                   January 2007--June 2007
  \[[@B80-nutrients-09-00474],[@B81-nutrients-09-00474]\]                                                           NS        247                  200       162        \-                  81                    81                   Advertisements in newspapers, on the Internet and medical centres.                                                                                                                     Community                                                   NS
  \[[@B91-nutrients-09-00474]\]                                                                                     863       118                  57        45         7                   48                    79                   E-mail invitations to in registry and longitudinal study of families of children affected by ASD.                                                                                      Online registry                                             18 September 2012--31 December 2012
  \[[@B67-nutrients-09-00474],[@B68-nutrients-09-00474]\]                                                           NS        NS                   75        59         \-                  \-                    79                   NS                                                                                                                                                                                     Hospital                                                    October 2004--August 2006
  \[[@B128-nutrients-09-00474]\]                                                                                    NS        NS                   138       108        \-                  \-                    78                   NS                                                                                                                                                                                     Outpatient clinic                                           March 2010--June 2012
  \[[@B122-nutrients-09-00474]\]                                                                                    NS        NS                   41        32         \-                  \-                    78                   NS                                                                                                                                                                                     School                                                      NS
  \[[@B106-nutrients-09-00474]\]                                                                                    NS        511                  450       348        \-                  88                    77                   Via school                                                                                                                                                                             Schools                                                     NS
  \[[@B89-nutrients-09-00474]\]                                                                                     NS        NS                   30        23         \-                  \-                    77                   NS                                                                                                                                                                                     Hospital                                                    January 1994--March 1995
  \[[@B142-nutrients-09-00474]\]                                                                                    NS        NS                   33        25         \-                  \-                    76                   Via community, hospital and through patient association.                                                                                                                               Community and referral                                      NS
  \[[@B69-nutrients-09-00474]\]                                                                                     NS        138                  76        57         \-                  55                    75                   School and parent group circulated screening information to all potential eligible families                                                                                            Schools and parent groups                                   NS
  \[[@B83-nutrients-09-00474]\]                                                                                     NS        351                  144       108        \-                  41                    75                   NS                                                                                                                                                                                     NS                                                          NS
  \[[@B77-nutrients-09-00474]\]                                                                                     250       102                  83        60         33                  81                    72                   Newspaper advertisement                                                                                                                                                                Community                                                   July 2004--January 2005
  \[[@B126-nutrients-09-00474]\]                                                                                    NS        NS                   28        20         \-                  \-                    71                   NS                                                                                                                                                                                     Hospital                                                    NS
  \[[@B93-nutrients-09-00474]\]                                                                                     NS        143                  48        34         \-                  34                    71                   Via recruitment flyers across campus and sent to autism support groups.                                                                                                                Campus, autism support groups                               NS
  \[[@B61-nutrients-09-00474]\]                                                                                     NS        NS                   37        26         \-                  \-                    70                   NS                                                                                                                                                                                     ADHD clinic                                                 NS
  \[[@B90-nutrients-09-00474]\]                                                                                     NS        32                   27        19         \-                  84                    70                   NS                                                                                                                                                                                     Outpatient autism clinic                                    5 November 2008--25 June 2009
  \[[@B84-nutrients-09-00474]\]                                                                                     NR        NR                   37        26         \-                  \-                    70                   NS                                                                                                                                                                                     NS                                                          NS
  \[[@B104-nutrients-09-00474]\]                                                                                    NS        162                  154       105        \-                  95                    68                   Via teachers who informed families                                                                                                                                                     School                                                      December 2009--July 2011
  \[[@B76-nutrients-09-00474]\]                                                                                     NS        193                  50        33         \-                  26                    66                   NS                                                                                                                                                                                     Community                                                   NS
  \[[@B74-nutrients-09-00474],[@B75-nutrients-09-00474]\]                                                           NS        201                  167       109        \-                  83                    65                   NS                                                                                                                                                                                     NS                                                          Start March--May 2004
  \[[@B70-nutrients-09-00474]\]                                                                                     NS        199                  96        57         \-                  48                    59                   Via media releases, television interviews, newspaper advertisements, school newsletters, and flyers.                                                                                   Community and School                                        June 2007--June 2009
  \[[@B110-nutrients-09-00474]\]                                                                                    560       447                  408       227        73                  91                    56                   Via information sessions and school newsletters.                                                                                                                                       Schools                                                     December 2010--May 2011
  \[[@B94-nutrients-09-00474]\]                                                                                     NS        NS                   51        24         \-                  \-                    47                   NS                                                                                                                                                                                     Hospital                                                    November 2001--March 2005
  \[[@B63-nutrients-09-00474]\]                                                                                     NS        NS                   40        17         \-                  \-                    43                   NS                                                                                                                                                                                     ADHD clinic                                                 NS
  \[[@B59-nutrients-09-00474]\]                                                                                     NS        NS                   40        NS         \-                  \-                    \-                   NS                                                                                                                                                                                     Outpatient ADHD clinic                                      June 2009--March 2010
  \[[@B124-nutrients-09-00474]\]                                                                                    NS        NS                   25        NR         \-                  \-                    \-                   NS                                                                                                                                                                                     Hospital                                                    NS
  \[[@B140-nutrients-09-00474]\]                                                                                    142       NS                   76        NS         54                  \-                    \-                   From previous sample children with insulin resistance were identified and invited                                                                                                      Community                                                   NS
  \[[@B102-nutrients-09-00474]\]                                                                                    NS        NS                   233       NS         \-                  \-                    \-                   Via school                                                                                                                                                                             School                                                      NS
  \[[@B100-nutrients-09-00474]\]                                                                                    NS        NS                   70        NS         \-                  \-                    \-                   NS                                                                                                                                                                                     Hospital                                                    NS
  \[[@B96-nutrients-09-00474]\]                                                                                     NS        NS                   38        NS         \-                  \-                    \-                   NS                                                                                                                                                                                     Hospital                                                    NS

NS = not specified.
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###### 

Adherence and drop out characteristics per study.

  Reference                                                                                                         Adherence Assessment                                         Adherence Mean or nr. of Part. Non-Adherent                                                     Blood FA Determined?   Drop-Out Rate (%)               
  ----------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------ ----------------------------------------------------------------------------------------------- ---------------------- ------------------------------- ------------------------
  **Healthy**                                                                                                                                                                                                                                                                                                                           
  \[[@B114-nutrients-09-00474]\]                                                                                    Supervision and tick-off form                                Active: 88.4%, Placebo: 88.5%                                                                   Y                      3.1                             6.1
  \[[@B115-nutrients-09-00474]\]                                                                                    Supervision                                                  NR                                                                                              Y                      0                               0
  \[[@B108-nutrients-09-00474]\]                                                                                    NR                                                           NR                                                                                              Y                      Low DHA: 20; High DHA: 7.1      17
  \[[@B112-nutrients-09-00474]\]                                                                                    Capsule count                                                Nearly 100%                                                                                     Y                      7.1                             5.6
  \[[@B101-nutrients-09-00474]\]                                                                                    Supervision                                                  Active: 94.8%, Placebo: 94.5%                                                                   Y                      11                              9.8
  \[[@B106-nutrients-09-00474]\]                                                                                    Pill diary by teacher or parent                              Active: 68.4%, Placebo: 66.7%                                                                   Y                      24                              21
  \[[@B102-nutrients-09-00474]\]                                                                                    NR                                                           NR                                                                                              Y                      NR                              NR
  \[[@B103-nutrients-09-00474]\]                                                                                    NR                                                           \>90%.                                                                                          Y                      6.7                             7.8
  \[[@B109-nutrients-09-00474]\]                                                                                    Sachet count and diary (Australia)/Supervision (Indonesia)   Australia: 73-84%                                                                               Y                      27                              34
  Indonesia: 85-87%                                                                                                                                                              3.6                                                                                             5.3                                                    
  \[[@B111-nutrients-09-00474]\]                                                                                    Interview                                                    small increase in DHA in supplemented group                                                     Y                      NR                              NR
  \[[@B107-nutrients-09-00474]\]                                                                                    Diary                                                        *n* = 6                                                                                         Y                      NR                              NR
  \[[@B105-nutrients-09-00474]\]                                                                                    Parental signing of diary card                               \>80%.                                                                                          N                      NR                              NR
  \[[@B113-nutrients-09-00474]\]                                                                                    NR                                                           NR                                                                                              N                      5.9                             19
  \[[@B110-nutrients-09-00474]\]                                                                                    Supervision                                                  Phase 1: 59%, Phase 2: 61%                                                                      N                      47                              42
  **With disorder or illness**                                                                                                                                                                                                                                                                                                          
  \[[@B141-nutrients-09-00474]\]                                                                                    NR                                                           NR                                                                                              Y                      0                               0
  \[[@B140-nutrients-09-00474]\]                                                                                    Pill count                                                   Active: 93%, Placebo: 96%                                                                       Y                      NR                              NR
  \[[@B82-nutrients-09-00474]\]                                                                                     Supervision                                                  count of consumed eggs showed good compliance and % of adherence to treatment was 100%          Y                      5.6                             3.2
  \[[@B127-nutrients-09-00474]\]                                                                                    Pill count                                                   pill count revealed no essential irregularities                                                 Y                      13.3                            Vit. E: 0, Placebo: 10
  \[[@B84-nutrients-09-00474]\]                                                                                     NR                                                           NR                                                                                              NR                     NR                              NR
  \[[@B80-nutrients-09-00474],[@B81-nutrients-09-00474]\]                                                           Pill count                                                   *n* = 14                                                                                        N                      20                              18
  \[[@B83-nutrients-09-00474]\]                                                                                     Pill count, compliance diary and telephone call              96.7%                                                                                           N                      23                              23
  \[[@B95-nutrients-09-00474]\]                                                                                     NR                                                           *n* = 2 DHA supplementation induced a median plasma DHA enrichment of 5% suggesting adherence   Y                      14                              5
  \[[@B138-nutrients-09-00474],[@B139-nutrients-09-00474]\]                                                         Interview                                                    90%                                                                                             Y                      NR                              NR
  \[[@B79-nutrients-09-00474]\]                                                                                     Capsule count                                                *n* = 1                                                                                         Y                      13                              11
  \[[@B86-nutrients-09-00474]\]                                                                                     Diary and blood values                                       80--85%                                                                                         Y                      21.1                            11.1
  \[[@B77-nutrients-09-00474]\]                                                                                     Phone calls and product weighting                            *n* = 6                                                                                         Y                      Phospholips: 38, Fish oil: 25   24
  \[[@B118-nutrients-09-00474],[@B119-nutrients-09-00474],[@B120-nutrients-09-00474],[@B121-nutrients-09-00474]\]   Supervision                                                  95.4%                                                                                           Y                      6.9                             9.9
  \[[@B61-nutrients-09-00474]\]                                                                                     Blood                                                        NR                                                                                              Y                      CO                              CO
  \[[@B94-nutrients-09-00474]\]                                                                                     Capsule count and diary                                      \>75%                                                                                           Y                      42                              64
  \[[@B70-nutrients-09-00474]\]                                                                                     Capsule count                                                EPA: 83%, DHA: 86% , LA: 85%                                                                    Y                      CO                              CO
  \[[@B87-nutrients-09-00474]\]                                                                                     Capsule count                                                75%                                                                                             Y                      NR                              NR
  \[[@B76-nutrients-09-00474]\]                                                                                     Diary                                                        88%                                                                                             Y                      28                              40
  \[[@B143-nutrients-09-00474],[@B144-nutrients-09-00474],[@B145-nutrients-09-00474]\]                              NR                                                           NR                                                                                              Y                      17                              17
  \[[@B131-nutrients-09-00474],[@B132-nutrients-09-00474],[@B133-nutrients-09-00474]\]                              Capsule count and interview                                  excellent in all groups                                                                         Y                      NR                              NR
  \[[@B62-nutrients-09-00474]\]                                                                                     Product weighting                                            *n* = 1                                                                                         Y                      0                               5.1
  \[[@B135-nutrients-09-00474]\]                                                                                    Capsule count and interview                                  NR                                                                                              Y                      0                               25
  \[[@B78-nutrients-09-00474]\]                                                                                     Capsule count                                                Active: 96.7%, Placebo: 100%                                                                    Y                      15                              13
  \[[@B93-nutrients-09-00474]\]                                                                                     Capsule count                                                excellent                                                                                       Y                      21                              38
  \[[@B136-nutrients-09-00474],[@B137-nutrients-09-00474]\]                                                         Capsule count                                                *n* = 1                                                                                         Y                      CO                              CO
  \[[@B90-nutrients-09-00474]\]                                                                                     Parent interview                                             Active: 69%, Placebo: 75%                                                                       Y                      36                              23
  \[[@B69-nutrients-09-00474]\]                                                                                     Capsule count                                                FA changed in the expected direction.                                                           Y                      24                              30
  \[[@B89-nutrients-09-00474]\]                                                                                     NR                                                           NR                                                                                              Y                      27                              14
  \[[@B64-nutrients-09-00474]\]                                                                                     Capsule count                                                NR                                                                                              Y                      30                              19
  \[[@B116-nutrients-09-00474]\]                                                                                    Capsule count                                                DHA: 96.5%, DHA + EPA: 96.9%, Placebo: 96.7%                                                    Y                      DHA: 0, DHA + EPA: 0            0
  \[[@B117-nutrients-09-00474]\]                                                                                    Blood value                                                  NR                                                                                              Y                      CO                              CO
  \[[@B129-nutrients-09-00474],[@B130-nutrients-09-00474]\]                                                         Capsule count                                                95.5%                                                                                           Y                      21                              11
  \[[@B128-nutrients-09-00474]\]                                                                                    Capsule count                                                NR                                                                                              Y                      NR                              NR
  \[[@B134-nutrients-09-00474]\]                                                                                    Blood values                                                 *n* = 5                                                                                         Y                      14                              10
  \[[@B98-nutrients-09-00474]\]                                                                                     NR                                                           According to parents children took the capsules carefully                                       Y                      NR                              NR
  \[[@B88-nutrients-09-00474]\]                                                                                     Supervision and capsule count                                Pill count: 91%                                                                                 Y                      0                               0
  \[[@B92-nutrients-09-00474]\]                                                                                     NR                                                           there was no overlap between the distributions of plasma levels between groups at week 24       Y                      21                              11
  \[[@B65-nutrients-09-00474]\]                                                                                     Capsule count                                                *n* = 5                                                                                         N                      NR                              NR
  \[[@B97-nutrients-09-00474]\]                                                                                     Capsule count and diary                                      Period 1: 88.7%, Period 2: 85.5%                                                                N                      17                              12
  \[[@B91-nutrients-09-00474]\]                                                                                     Parents e-mail                                               Active: 69%, Placebo: 83%                                                                       N                      28                              14
  \[[@B85-nutrients-09-00474]\]                                                                                     Parent interview and blood values                            Average number of drink per week 6.5.                                                           N                      10                              22
  \[[@B73-nutrients-09-00474]\]                                                                                     Capsule count                                                Active 7.88 capsules left; Placebo: 14 capsules left                                            N                      18                              21
  \[[@B125-nutrients-09-00474]\]                                                                                    NR                                                           89--97%                                                                                         N                      10                              23
  \[[@B142-nutrients-09-00474]\]                                                                                    NR                                                           NR                                                                                              N                      18                              31
  \[[@B67-nutrients-09-00474],[@B68-nutrients-09-00474]\]                                                           Parent interview                                             Period 1: 93.4%, Period 2: 93.3%                                                                N                      CO                              CO
  \[[@B126-nutrients-09-00474]\]                                                                                    NR                                                           *n* = 5                                                                                         N                      NR                              NR
  \[[@B122-nutrients-09-00474]\]                                                                                    Capsule count                                                Active: 90.4%, placebo 86.6%                                                                    N                      23                              21
  \[[@B74-nutrients-09-00474],[@B75-nutrients-09-00474]\]                                                           Capsule count and diary                                      *n* = 2                                                                                         N                      CO                              CO
  \[[@B63-nutrients-09-00474]\]                                                                                     Capsule count                                                NR                                                                                              N                      60                              55
  \[[@B59-nutrients-09-00474]\]                                                                                     NR                                                           NR                                                                                              N                      NR                              NR
  \[[@B124-nutrients-09-00474]\]                                                                                    NR                                                           NR                                                                                              N                      NR                              NR
  \[[@B100-nutrients-09-00474]\]                                                                                    NR                                                           NR                                                                                              N                      NR                              NR
  \[[@B96-nutrients-09-00474]\]                                                                                     NR                                                           Compliance was optimal                                                                          N                      NR                              NR
  \[[@B66-nutrients-09-00474]\]                                                                                     NR                                                           NR                                                                                              N                      0                               0
  \[[@B146-nutrients-09-00474],[@B147-nutrients-09-00474]\]                                                         Diary                                                        At school: 75%                                                                                  N                      0.6                             1.1
  \[[@B72-nutrients-09-00474]\]                                                                                     NR                                                           NR                                                                                              N                      2                               6.1
  \[[@B58-nutrients-09-00474]\]                                                                                     NR                                                           *n* = 5                                                                                         N                      8.6                             5.7
  \[[@B60-nutrients-09-00474]\]                                                                                     NR                                                           NR                                                                                              N                      NR                              NR
  \[[@B123-nutrients-09-00474]\]                                                                                    Diary and capsule count                                      NR                                                                                              N                      0                               20
  \[[@B104-nutrients-09-00474]\]                                                                                    Interview                                                    Active: 94%, Placebo: 92%, Period 2: 91%                                                        N                      CO                              CO
  \[[@B99-nutrients-09-00474]\]                                                                                     NR                                                           *n* = 1                                                                                         N                      CO                              CO

CO: cross-over study, NR: not reported.
